Homocysteine - Relevant for atherogenesis?

Wiener Klinische Wochenschrift

Volumn 112, Issue 12, 2000, Pages 523-532

  Kircher, Thomas ^b   Sinzinger, Helmut ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

Atherosclerosis; B vitamins; Cardiovascular disease; Folic acid; Homocysteine; Prospective studies; Retrospective studies; Risk factor

Indexed keywords

COBAMAMIDE; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE DERIVATIVE;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; FAMILY HISTORY; FOLIC ACID BLOOD LEVEL; GENE MUTATION; HIGH RISK PATIENT; HYPERHOMOCYSTEINEMIA; REVIEW; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION;

ARTERIOSCLEROSIS; CASE-CONTROL STUDIES; CORONARY DISEASE; FOLIC ACID; HEMATINICS; HUMANS; HYPERHOMOCYSTEINEMIA; PROSPECTIVE STUDIES; PYRIDOXINE; RETROSPECTIVE STUDIES; RISK FACTORS; VITAMIN B 12;

EID: 0034674359     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Lupattelli G, Rufini S, Vasa S, Locati E, Lombardini R, Ciufetti G, Siepi D, Mannarino E (2000) Hyperhomocysteinemia is associated with carotid atherosclerosis. VASA (in press)
2. Ubbink JB, Vermaak WJH, Bennett JM, Becker JP, van Staden DA, Bissbort S (1991) The prevalence of hyperhomocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease. Klin Wochenschr 69: 527-534
3. Dalery K, Lussier-Cacan S, Selhub J, Davignon J, Latour Y, Genest J (1995) Homocysteine and coronary heart artery disease in French Canadian subjects: relation with vitamins B12. pyridoxal phosphate and folate. Am J Cardiol 75: 1102-1111
4. Pancharuniti N, Lewis CA, Sauberlich HE, Perkins LL, Go RCP, Alvarez JO, Macaluso M, Acton RT, Copeland RB, Cousins AL, Gore TB, Cornwell PE, Roseman JM (1994) Plasma homocyst(e)ine, folate, and vitamin B12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr 59: 940-948
5. Israelsson B, Brattstrom LE, Hultberg BL (1988) Homocysteine and myocardial infarction. Atherosclerosis 71: 227-233
6. Wu LL, Wu J, Hunt SC, James BC, Vincent GM, Williams RR, Hopkins PN (1994) Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. Clin Chem 40: 552-561
7. Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, Reynolds RD, Kok FJ, Hennekens CH, Willett WC (1996) Homocysteine metabolism and risk for myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol 143: 845-859
8. Malinow MR (1994) Homocyst(e)ine and arterial occlusive disease. J Intern Med 236: 603-617
9. Nygard O, Stein EV, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland PM, Kvale G (1995) Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteine study. JAMA 274: 1526-1533
10. Verhoef PK, Kryssen DACM, Schouten EG, Witteman JCM, Grobbee DE, Ueland PM, Refsum H (1997) Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler Thromb Vase Biol 17: 989-995
11. Bots ML, Launer LJ, Lindemans J, Hofman A, Grobbee DE (1997) Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: The Rotterdam Study. J Intern Med 242: 339-347
12. Genest JJ, McNamara JR, Salem DN, Wilson PWF, Schaefer EJ, Malinow NM (1990) Plasma homocyst(e)ine levels in men with premature coronary artery disease. Am J Coll Cardiol 16: 1114-1119
13. Refsum H, Fiskerstrand T, Guttormsen B, Ueland PM (1997) Assessment of homocysteine status. J Inher Metab Dis 20: 286-294
14. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen HR (1993) Total homocysteine in plasma or serum: Methods and clinical applications. Clin Chem 39: 1764-1779
15. Guttormsen A, Schneede J, Fiskerstrand T, Ueland PM, Refsum HM (1994) Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects. J Nutr 124: 1934-1941
16. Leppanen EA, Grasbeck R (1988) Experimental basis of standardized specimen collection: effect of posture on blood picture. Eur J Haematol 40: 222-226
17. Clarke R, Woodhouse P, Ulvik A, Frost C, Sherliker P, Refsum H, Ueland PM, Khaw KT (1998) Variability and determinants of total homocysteine concentrations in plasma in an elderly population. Clin Chem 44: 102-107
18. Garg UC, Zheng ZJ, Folsom AR, Moyer YS, Tsai MY, McGovern P, Eckfeld JH (1997) Short term and long term variability of plasma homocysteine measurement. Clin Chem 43: 141-145
19. Rossi E, Beilby JP, McQuillan BM, Hung J (1999) Biological variability and reference intervals for total plasma homocysteine. Ann Clin Biochem 36: 56-61
20. Alfthan G, Antti A, Gey F (1997) Plasma homocysteine and cardiovascular disease mortality. Lancet 349: 397
21. Lentz SR, Malinow MR, Donald JP, Bhopatkar-Teredesai M, Faraci FM, Heistad DD (1997) Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys. Arterioscler Thromb Vase Biol 17: 2930-2934
22. Alfthan G, Pekkanen J, Jauhiaininen M, Pitakäniemi J, Karvonen M, Tuomilehto J, Salonen JT, Ehnholm C (1994) Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 106: 9-19
23. Evans RW, Shaten BJ, Hempel JD, Cutler JA, Kuller LH (1997) Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial. Arterioscler Thromb Vasc Biol 17: 1947-1953
24. Folsom AR, Nicto J, Mc Govern PG, Tsai NIY, Malinow MR, Eckfeldt JH, Hess DL, Davis CE (1998) Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B-vitamins. The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 8: 204-210
25. Ubbink JB, Fehily AM, Pickering J, Elwood PC, Verinaak WJ (1998) Homocysteine and ischaemic heart disease in the Caerphilly cohort. Atherosclerosis 140: 349-356
26. Verhoef P, Hennekens CH, Allen RH, Stabler SP, Willett WC, Stampfer MJ (1997) Plasma total homocysteine and risk of angina pectoris with subsequent coronary artery bypass surgery. Am J Cardiol 79: 799-801
27. Rees MM, Rodgers GM (1993) Homocysteinemia: Association of a metabolic disorder with vascular disease and thrombosis. Thromb Res 71: 337-359
28. Fowler B (1997) Disorders of homocysteine metabolism. J Inher Metab Dis 20: 270-285
29. Mudd SH, Levy HL, Skovby F (1995) Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, et al (eds) The metabolic basis of inherited disease, 7th edn. McGraw-Hill Book Company, New York, pp 1297-1327
30. Stein JH, McBride PE (1998) Hyperhomocysteinemia and atherosclerotic vascular disease. Arch Intern Med 158: 1301-1306
31. Leclerc D, Wilson A, Duinas R, Grafuik C, Song D, Watkins D, Heng HH, Rommens JM, Scherer SW, Rosenblatt DS, Gravel RA (1998) Cloning and mapping of a CDNA for methionine synthase reductase, a flavo-proteine defective in patients with homocysteinuria. Proc Natl Acad Sci USA 95: 3059-3064
32. Kang SS, Wong PWK, Bock HG, Horwitz A, Grix A (1991) Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations. J Am Hum Genetic 48: 546
33. Ueland PM, Refsum H (1989) Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lib Clin Med 114: 473-501
34. Kang SS, Wong PWK, Norusis M (1987) Homocysteinemia due to folate deficiency. Metabolism 36: 458-462
35. Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ (1993) Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 57: 47-53
36. Landray MJ, Townend JN, Martin S, Martin U, Wheeler DC (1999) Lipid-lowering drugs and homocysteine. The Lancet 353: 1974-1975
37. Cravo ML, Gloria LM, Seihub J, Nadeau NIR, Camilo NIE, Resende PM, Cardoso JN, Leitao CN, Mira FC (1996) Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status. Am J Clin Nutr 63: 220-224
38. Jacobsen DW (1998) Homocysteine and vitamins in cardiovascular disease. Clin Chem 44: 1833-1843
39. Wall RT, Harlan JM, Harker LA, Striker GE (1980) Homocysteine induced endothelial cell injury in vitro a model for the study of vascular injury. Thromb Res 18: 113
40. Starkebaum G, Harlan JM (1986) Endothelial cell injury due to copper - catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 77: 1370-1376
41. Dudman NPB, Hicks C, Wang J, Wilcken DEL (1991) Human arterial endothelial detachment in vitro: its promotion by homocysteine and cysteine. Atherosclerosis 91: 77-83
42. Bennan RS, Martin W (1993) Arterial endothelial barrier dysfunction: Actions of homocysteine and the lipoxanthine-xanthine oxidase free radical generating system. Br J Pharmacol 108: 920
43. Heinecke JW, Rosen H, Suzuki LA, Chait A (1987) The role of sulfur-containing amino acids in superoxide production and modification of low-density lipoprotein by arterial smooth muscle cells. J Biol Chem 262: 10098-10103
44. Mansoor MA, Svardal AM, Schnedde J, Ueland PM (1992) Dynamic relation between reduced, oxidized, and protein bound homocysteine and other thiol components in plasma during methionine loading in healthy men. Clin Chem 38: 1316-1321
45. Harker LA, Slichter SJ, Scott CR, Ross R (1974) Homocysteinemia: vascular injury and arterial thrombosis. N Engl J Med 291: 537
46. Harker LA, Ross R, Slichter SJ, Scott CR (1976) Homocysteine-induced arteriosclerosis: The role of endothelial cell injury and platelet response in its genesis. J Clin Invest 58: 731
47. McCully KS, Wilson RB (1975) Homocysteine theory of arteriosclerosis. J Clin Invest 58: 731
48. McCully KS, Ragsdale BD (1970) Production of arteriosclerosis by homocysteinemia. Am J Pathol 61: 1
49. Kuller LH, Evans RW (1998) Homocysteine, vitamins, and cardiovascular disease. Circulation 98: 196-199
50. Upchurch GR jr, Welch GN, Fabiah AJ, Freedman JE, Johnson JL, Keaney JF Jr, Loscalzo J (1997) Homocyst(e)ine decreases the bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 272: 25380-25385
51. Lentz SR (1997) Homocysteine and vascular dysfunction. Life Science 61: 1205-1215
52. Lentz SR, Evans JE (1993) Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmatic reticulum. Blood 81: 683-689
53. Tsai J-C, Wang H, Perella MA, Yoshizumi M, Hsie C-M, Sibinga NES, Tau LC, Haber E, Chang T, Schlegel R, Lee M (1997) Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest 97: 145-153
54. ras methylation in vascular endothelial cells by homocysteine but not cysteine. J Biol Chem 272: 17012-17017
55. Harpel PC, Chang VT, Borth W (1992) Homocysteine and other sulfhydryl compounds enhance the binding of lipoproteine(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism. Proc Natl Acad Sci USA 89: 10193-10197
56. Van den Berg M, Boers GHJ, Franken DG, Blom HJ, Van Kamp GJ, Jakobs C, Rauwerda JA, Kluft C, Stehouwert CD (1995) Hyperhomocysteinemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. Eur J Clin Invest 25: 176-181
57. Tawakol A, Omland T, Gerhard M, Wu JT, Craeger MA (1997) Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 95: 1119-1121
58. Amesen E, Refsum H, Bonaa KHH, Ueland PM, Forde OH, Nordrehaug JE (1995) Serum total homocysteine and cardiovascular disease. Int J Epidemiol 24: 704-709
59. Stampfer MJ, Malinow R, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH (1992) A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in United States physicians. JAMA 268: 877-881
60. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocyst(e)ine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 274: 1049-1057
61. Graham IM, Daly LE, Refsum HE. Robinson K, Brattström LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R, McMaster D, Verhoef P, Wittemann J, Rubba P, Bellet H, Wautrecht JC, de Valk HW, Sales-Luis AC, Parrot-Rouland FM, Kok Son Tan, Higgins I, Garcon D, Me-drano MJ, Candito M, Evans AE, Andria G (1997) Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277: 1775-1781
62. Stehouwer CDA, Weijenberg MP, van den Berg M, Jakobs C, Feskens EJM, Kromhout D (1998) Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men. A 10 year follow up. Arterioscler Thromb Vase Biol 18: 1895-1901
63. Wald NJ, Watt HC, Law NM, Weir DG, McPartlin J, Scott JM (1998) Homocysteine and ischemic heart disease. Results of a prospective study with implications regarding prevention. Arch Intern Med 158: 862-867
64. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324: 1149-1155
65. Brattström L, Lindgren A, Israelsson B, Malinow MR, Norrving BU, Hamfelt A (1992) Hyperhomocysteinemia in stroke: prevalence, causal, and relationship to type of stroke and stroke risk factors. Eur J Clin Invest 22: 214-221
66. Coull BM, Malinow NM, Beamer N, Sexton G, Nordt F, de Garmo P (1990) Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke 21: 572-576
67. Verhoef P, Hennekens CH, Malinow R, Kok F, Willett WC, Stampfer MJ (1994) A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke 25: 1924-1930
68. Bostom AG, Rosenberg IH, Silbershatz H, Jacques PF, D'Agostino RB, Wilson PW, Wolf PA (1999) Non-fasting plasma homocysteine levels and stroke incidence in elderly persons: the Framingham study. Ann Intern Med 131: 352-355
69. Malinow MR, Kang SS, Taylor LM, Wong PWK, Coull B, Inahara T, Mukerjee D, Sexton G, Upson B (1989) Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation 79: 1180-1188
70. Mölgaard J, Malinow MR, Lassvik C, Holm AC, Upson B, Olsson AG (1992) Hyperhomocyst(e)inemia: an independent risk factor for intermittent claudication. J Int Med 231: 273-279
71. Taylor LM jr, De Frang RD, Harris EJ jr, Porter JM (1991) The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. J Vasc Surg 13: 128-136
72. Bergmark C, Mansoor MA, Swedenborg J, de Faire LJ, Svardal ANL Ueland PM (1993) Hyperhomocysteinemia in patients operated for lower extremity ischemia below the age of 50 - effect of smoking and extent of disease. J Vasc Surg 7: 391-396
73. Valentine RJ, Kaplan HS, Green R, Jacobsen DW, Myers SI, Clagett GP (1996) Lipoprotein(a), homocysteine, and hypercoagulable states in young men with premature peripheral atherosclerosis: a prospective, controlled analysis. J Vasc Surg 23: 53-61
74. Tsakiris TA, Tschopl M, Jager K, Haefeli WE, Wolf F, Marbet GA (1999) Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease. Atherosclerosis 1: 193-200
75. Taylor LM, Moneta GL, Sexton GJ, Schuff RA, Porter JM (1999) Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease. J Vasc Surg 29: 8-19
76. Egerton W, Silberberg J, Crooks R, Riy C, Dudman N (1996) Serial measures of plasma homocyst(e)ine after myocardial infarction. Am J Cardiol 77: 759-761
77. Lindgren A, Brattström L, Norrving B, Hultberg B, Anderson A, Johansson BB (1995) Plasma homocysteine in the acute and convalescent phases after stroke. Stroke 26: 795-800
78. Kronenberg F (1998) Homocysteine, lipoprotein(a) and fibrinogen: metabolic risk factors for cardiovascular complications of chronic renal disease. Curr Opin Nephrol Hypertens 7: 271-278
79. Frantzen F, Faaren AL, Alfheim A, Nordhei AK (1998) Enzyme conversion immunoassay for determining total homocysteine in plasma or serum. Clin Chem 44: 311-316
80. Pietzsch J, Pixa A ( 1998) Determination of total homocysteine. Clin Chem 44: 1781-1782
81. Vester B, Rasmussen K (1991) High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Biochem 29: 549-554
82. van der Griend R, Haas JLM, Duran M, Biesma DH, Meuwissen OJATH, Banga JD (1998) Methionine loading test is necessary for detection of hyperhomocysteinemia. J Lib Clin Med 132:67-72
83. Gunter EW, Bowman BA, Caudill SP, Twite DB, Adams MJ, Sampson EJ (1996) Results of an international round robin for serum and whole-blood folate. Clin Chem 42/10: 1689-1694
84. Smulder YM, de Man AM, Stehouwer CD, Slaats EH (1998) Trimethoprim and fasting plasma homocysteine. Lancet 352: 1827-1828
85. Souci SW, Fachmann W, Kraut H (1994) Die Zusammensetzung der Lebensmittel. Nährwert-Tabellen. Medpharma Scientific Publication